iRhythm (IRTC) Stock Forecast, Price Target & Predictions
IRTC Stock Forecast
iRhythm stock forecast is as follows: an average price target of $121.17 (represents a 48.78% upside from IRTC’s last price of $81.44) and a rating consensus of 'Buy', based on 19 wall street analysts offering a 1-year stock forecast.
IRTC Price Target
The average price target for iRhythm (IRTC) is $121.17 based on 1-year price targets from 19 Wall Street analysts in the past 3 months, with a price target range of $190.00 to $78.00. This represents a potential 48.78% upside from IRTC's last price of $81.44.
IRTC Analyst Ratings
According to 19 Wall Street analysts, iRhythm's rating consensus is 'Buy'. The analyst rating breakdown for IRTC stock is 1 'Strong Buy' (5.26%), 15 'Buy' (78.95%), 3 'Hold' (15.79%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
iRhythm Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 31, 2024 | Michael Matson | Needham | $96.00 | $75.77 | 26.70% | 17.88% |
| Oct 22, 2024 | David Rescott | Truist Financial | $95.00 | $62.10 | 52.98% | 16.65% |
| Oct 15, 2024 | David Rescott | Robert W. Baird | $100.00 | $57.94 | 72.61% | 22.79% |
| Oct 14, 2024 | Richard Newitter | Truist Financial | $80.00 | $57.58 | 38.94% | -1.77% |
| Oct 04, 2024 | David Roman | Goldman Sachs | $78.00 | $66.28 | 17.68% | -4.22% |
| Sep 25, 2024 | William Plovanic | Canaccord Genuity | $137.00 | $70.30 | 94.88% | 68.22% |
| Aug 02, 2024 | Richard Newitter | Truist Financial | $117.00 | $75.44 | 55.09% | 43.66% |
| Aug 02, 2024 | Suraj Kalia | Oppenheimer | $145.00 | $84.22 | 72.17% | 78.05% |
| Aug 02, 2024 | Marie Thibault | BTIG | $125.00 | $84.22 | 48.42% | 53.49% |
| Jul 16, 2024 | Richard Newitter | Truist Financial | $134.00 | $102.76 | 30.40% | 64.54% |
The latest iRhythm stock forecast, released on Oct 31, 2024 by Michael Matson from Needham, set a price target of $96.00, which represents a 26.70% increase from the stock price at the time of the forecast ($75.77), and a 17.88% increase from IRTC last price ($81.44).
iRhythm Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 4 | 6 | 13 |
| Avg Price Target | $92.75 | $97.67 | $114.54 |
| Last Closing Price | $81.44 | $81.44 | $81.44 |
| Upside/Downside | 13.89% | 19.93% | 40.64% |
In the current month, the average price target of iRhythm stock is $92.75, according to 4 Wall Street analysts offering twelve months forecast. The average price target represents a 13.89% increase as opposed to iRhythm's last price of $81.44. This month's average price target is down -5.04% compared to last quarter, and down -19.02% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 31, 2024 | Needham | Buy | Buy | Hold |
| Oct 22, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Oct 22, 2024 | BTIG | Buy | Buy | Hold |
| Oct 04, 2024 | Goldman Sachs | - | Neutral | Initialise |
| Aug 02, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Aug 02, 2024 | BTIG | Buy | Buy | Hold |
| Jun 20, 2024 | Wolfe Research | - | Outperform | Upgrade |
| May 29, 2024 | BTIG | Buy | Buy | Hold |
| May 20, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| May 06, 2024 | Citigroup | Buy | Buy | Hold |
iRhythm's last stock rating was published by Needham on Oct 31, 2024. The company gave IRTC a "Buy" rating, the same as its previous rate.
iRhythm Financial Forecast
iRhythm Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $124.60M | $124.13M | $111.44M | $112.62M | $103.88M | $102.05M | $92.38M | $81.80M | $85.43M | $81.28M | $74.31M | $78.81M | $71.94M | $50.88M | $63.53M | $59.10M | $54.67M |
| Avg Forecast | $215.15M | $201.01M | $201.89M | $181.58M | $182.82M | $171.62M | $172.43M | $154.38M | $157.18M | $147.00M | $146.15M | $128.41M | $130.20M | $122.61M | $120.29M | $107.05M | $110.26M | $105.86M | $100.36M | $86.76M | $78.30M | $83.89M | $72.71M | $70.27M | $76.59M | $62.34M | $42.18M | $61.40M | $58.42M | $53.75M |
| High Forecast | $217.88M | $203.56M | $204.45M | $183.89M | $185.14M | $173.80M | $174.61M | $155.43M | $158.71M | $147.06M | $146.15M | $128.41M | $133.56M | $123.64M | $121.82M | $108.41M | $111.66M | $105.86M | $100.36M | $86.76M | $78.30M | $83.89M | $72.71M | $70.27M | $76.59M | $62.34M | $42.18M | $61.40M | $58.42M | $53.75M |
| Low Forecast | $213.00M | $199.00M | $199.88M | $179.77M | $181.00M | $169.91M | $170.70M | $153.48M | $155.65M | $146.94M | $146.15M | $128.41M | $129.14M | $121.31M | $119.09M | $105.98M | $109.16M | $105.86M | $100.36M | $86.76M | $78.30M | $83.89M | $72.71M | $70.27M | $76.59M | $62.34M | $42.18M | $61.40M | $58.42M | $53.75M |
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 4 | 4 | 5 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.03% | 1.04% | 1.02% | 0.98% | 1.02% | 1.06% | 1.04% | 1.02% | 1.12% | 1.06% | 1.03% | 1.15% | 1.21% | 1.03% | 1.01% | 1.02% |
iRhythm's average Quarter revenue forecast for Dec 23 based on 5 analysts is $130.20M, with a low forecast of $129.14M, and a high forecast of $133.56M. IRTC's average Quarter revenue forecast represents a 4.49% increase compared to the company's last Quarter revenue of $124.60M (Sep 23).
iRhythm EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 4 | 4 | 5 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-27.60M | $-18.87M | $-33.13M | $-19.11M | $-20.72M | $-18.71M | $-12.24M | $-34.12M | $-19.00M | $-13.11M | $-23.75M | $-11.82M | $-975.00K | $-16.77M | $-5.62M | $-23.16M | $-14.51M |
| Avg Forecast | $-47.68M | $-44.55M | $-44.74M | $-40.24M | $-40.52M | $-38.03M | $-38.21M | $-34.21M | $-34.83M | $-32.58M | $-32.39M | $-59.19M | $-28.85M | $-27.17M | $-26.66M | $-53.80M | $-39.78M | $-23.46M | $-22.24M | $-48.91M | $-17.35M | $-18.59M | $-16.11M | $-20.32M | $-16.97M | $-13.82M | $-9.35M | $-7.20M | $-12.95M | $-11.91M |
| High Forecast | $-47.20M | $-44.10M | $-44.30M | $-39.84M | $-40.11M | $-37.65M | $-37.83M | $-34.01M | $-34.49M | $-32.56M | $-32.39M | $-47.35M | $-28.62M | $-26.88M | $-26.39M | $-43.04M | $-31.82M | $-23.46M | $-22.24M | $-39.13M | $-17.35M | $-18.59M | $-16.11M | $-16.26M | $-16.97M | $-13.82M | $-9.35M | $-5.76M | $-12.95M | $-11.91M |
| Low Forecast | $-48.29M | $-45.11M | $-45.31M | $-40.75M | $-41.03M | $-38.52M | $-38.70M | $-34.45M | $-35.17M | $-32.59M | $-32.39M | $-71.02M | $-29.60M | $-27.40M | $-27.00M | $-64.57M | $-47.73M | $-23.46M | $-22.24M | $-58.70M | $-17.35M | $-18.59M | $-16.11M | $-24.38M | $-16.97M | $-13.82M | $-9.35M | $-8.64M | $-12.95M | $-11.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.71% | 0.62% | 0.48% | 0.88% | 0.84% | 0.25% | 1.97% | 1.02% | 0.81% | 1.17% | 0.70% | 0.07% | 1.79% | 0.78% | 1.79% | 1.22% |
undefined analysts predict IRTC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than iRhythm's previous annual EBITDA (undefined) of $NaN.
iRhythm Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 4 | 4 | 5 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-27.12M | $-18.48M | $-39.11M | $-20.20M | $-21.45M | $-23.90M | $-50.61M | $-32.49M | $-23.73M | $-17.36M | $-27.78M | $-9.65M | $-4.68M | $-20.44M | $-9.06M | $-17.30M | $-18.29M |
| Avg Forecast | $-412.66K | $-4.76M | $-4.15M | $-16.88M | $-9.96M | $-14.71M | $-15.46M | $-21.57M | $-11.47M | $-24.84M | $-27.93M | $-77.11M | $-18.09M | $-19.90M | $-23.80M | $-70.10M | $-37.88M | $-25.44M | $-28.46M | $-63.73M | $-36.42M | $-31.86M | $-29.39M | $-23.76M | $-9.11M | $-15.99M | $-24.96M | $-11.62M | $-16.50M | $-12.25M |
| High Forecast | $-407.30K | $-4.70M | $-4.09M | $-16.66M | $-9.84M | $-14.52M | $-15.26M | $-14.38M | $-7.64M | $-24.52M | $-27.57M | $-61.69M | $-7.54M | $-16.58M | $-23.50M | $-56.08M | $-30.30M | $-25.44M | $-28.46M | $-50.98M | $-36.42M | $-31.86M | $-29.39M | $-19.01M | $-9.11M | $-15.99M | $-24.96M | $-9.29M | $-16.50M | $-12.25M |
| Low Forecast | $-419.47K | $-4.84M | $-4.22M | $-17.16M | $-10.13M | $-14.95M | $-15.71M | $-28.76M | $-17.58M | $-25.25M | $-28.39M | $-92.54M | $-24.42M | $-22.61M | $-24.20M | $-84.12M | $-45.45M | $-25.44M | $-28.46M | $-76.48M | $-36.42M | $-31.86M | $-29.39M | $-28.52M | $-9.11M | $-15.99M | $-24.96M | $-13.94M | $-16.50M | $-12.25M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.36% | 0.78% | 0.56% | 0.53% | 0.84% | 0.84% | 0.79% | 0.89% | 0.74% | 0.59% | 1.17% | 1.06% | 0.29% | 0.82% | 0.78% | 1.05% | 1.49% |
iRhythm's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. IRTC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
iRhythm SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 4 | 4 | 5 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $93.77M | $91.42M | $100.34M | $86.73M | $80.56M | $81.75M | $73.16M | $71.61M | $70.75M | $62.67M | $69.81M | $56.29M | $49.70M | $43.01M | $48.23M | $53.65M | $45.65M |
| Avg Forecast | $172.06M | $160.76M | $161.46M | $145.22M | $146.21M | $137.25M | $137.90M | $123.46M | $125.70M | $117.56M | $116.89M | $111.47M | $104.13M | $98.05M | $96.20M | $101.34M | $83.49M | $84.66M | $80.26M | $69.38M | $62.62M | $67.09M | $58.15M | $59.72M | $61.26M | $49.86M | $33.74M | $49.11M | $46.72M | $42.99M |
| High Forecast | $174.25M | $162.80M | $163.51M | $147.06M | $148.07M | $138.99M | $139.65M | $124.31M | $126.92M | $117.61M | $116.89M | $133.77M | $106.82M | $98.88M | $97.43M | $121.60M | $100.18M | $84.66M | $80.26M | $69.38M | $62.62M | $67.09M | $58.15M | $71.66M | $61.26M | $49.86M | $33.74M | $49.11M | $46.72M | $42.99M |
| Low Forecast | $170.35M | $159.15M | $159.85M | $143.77M | $144.75M | $135.88M | $136.52M | $122.74M | $124.48M | $117.51M | $116.89M | $89.18M | $103.28M | $97.01M | $95.24M | $81.07M | $66.79M | $84.66M | $80.26M | $69.38M | $62.62M | $67.09M | $58.15M | $47.78M | $61.26M | $49.86M | $33.74M | $49.11M | $46.72M | $42.99M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.95% | 0.99% | 1.04% | 0.95% | 1.02% | 1.05% | 1.14% | 1.05% | 1.08% | 1.17% | 0.92% | 1.00% | 1.28% | 0.98% | 1.15% | 1.06% |
iRhythm's average Quarter SG&A projection for Dec 23 is $104.13M, based on 5 Wall Street analysts, with a range of $103.28M to $106.82M. The forecast indicates a 11.05% rise compared to IRTC last annual SG&A of $93.77M (Sep 23).
iRhythm EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 8 | 4 | 4 | 4 | 5 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 15 | 9 | 9 | 16 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.89 | $-0.61 | $-1.29 | $-0.67 | $-0.71 | $-0.80 | $-1.71 | $-1.10 | $-0.81 | $-0.59 | $-0.95 | $-0.33 | $-0.17 | $-0.75 | $-0.34 | $-0.65 | $-0.74 |
| Avg Forecast | $-0.01 | $-0.15 | $-0.13 | $-0.54 | $-0.32 | $-0.47 | $-0.49 | $-0.69 | $-0.37 | $-0.79 | $-0.89 | $-0.97 | $-0.58 | $-0.64 | $-0.76 | $-0.90 | $-0.63 | $-0.82 | $-0.91 | $-1.10 | $-1.17 | $-1.02 | $-0.94 | $-0.83 | $-0.29 | $-0.51 | $-0.80 | $-0.59 | $-0.53 | $-0.39 |
| High Forecast | $-0.01 | $-0.15 | $-0.13 | $-0.53 | $-0.31 | $-0.46 | $-0.49 | $-0.46 | $-0.24 | $-0.78 | $-0.88 | $-0.96 | $-0.24 | $-0.53 | $-0.75 | $-0.89 | $-0.62 | $-0.82 | $-0.91 | $-1.10 | $-1.17 | $-1.02 | $-0.94 | $-0.83 | $-0.29 | $-0.51 | $-0.80 | $-0.59 | $-0.53 | $-0.39 |
| Low Forecast | $-0.01 | $-0.15 | $-0.13 | $-0.55 | $-0.32 | $-0.48 | $-0.50 | $-0.92 | $-0.56 | $-0.81 | $-0.91 | $-0.99 | $-0.78 | $-0.72 | $-0.77 | $-0.91 | $-0.64 | $-0.82 | $-0.91 | $-1.10 | $-1.17 | $-1.02 | $-0.94 | $-0.83 | $-0.29 | $-0.51 | $-0.80 | $-0.59 | $-0.53 | $-0.39 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.40% | 0.80% | 1.44% | 1.07% | 0.87% | 0.88% | 1.56% | 0.94% | 0.79% | 0.63% | 1.14% | 1.13% | 0.33% | 0.94% | 0.57% | 1.23% | 1.88% |
According to undefined Wall Street analysts, iRhythm's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to IRTC previous annual EPS of $NaN (undefined).
iRhythm Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SGHT | Sight Sciences | $4.66 | $10.25 | 119.96% | Hold |
| NPCE | NeuroPace | $6.37 | $12.88 | 102.20% | Buy |
| FNA | Paragon 28 | $6.06 | $11.50 | 89.77% | Buy |
| OFIX | Orthofix Medical | $17.33 | $31.00 | 78.88% | - |
| IRTC | iRhythm | $81.44 | $121.17 | 48.78% | Buy |
| LIVN | LivaNova | $49.01 | $70.50 | 43.85% | Buy |
| KIDS | OrthoPediatrics | $28.74 | $39.60 | 37.79% | Buy |
| CNMD | CONMED | $70.47 | $96.00 | 36.23% | Buy |
| BRKR | Bruker | $59.35 | $73.75 | 24.26% | Buy |
| ITGR | Integer | $126.53 | $138.00 | 9.07% | Buy |
| SRDX | Surmodics | $37.57 | $39.50 | 5.14% | Buy |
| GKOS | Glaukos | $131.38 | $119.33 | -9.17% | Buy |
IRTC Forecast FAQ
Is iRhythm a good buy?
Yes, according to 19 Wall Street analysts, iRhythm (IRTC) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 15 'Buy' recommendations, accounting for 84.21% of IRTC's total ratings.
What is IRTC's price target?
iRhythm (IRTC) average price target is $121.17 with a range of $78 to $190, implying a 48.78% from its last price of $81.44. The data is based on 19 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will iRhythm stock go up soon?
According to Wall Street analysts' prediction for IRTC stock, the company can go up by 48.78% (from the last price of $81.44 to the average price target of $121.17), up by 133.30% based on the highest stock price target, and down by -4.22% based on the lowest stock price target.
Can iRhythm stock reach $120?
IRTC's average twelve months analyst stock price target of $121.17 supports the claim that iRhythm can reach $120 in the near future.
What is iRhythm's current price target trend?
4 Wall Street analysts forecast a $92.75 price target for iRhythm (IRTC) this month, up 13.89% from its last price of $81.44. Compared to the last 3 and 12 months, the average price target increased by 19.93% and increased by 40.64%, respectively.
What are iRhythm's analysts' financial forecasts?
iRhythm's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $681.24M (high $688.99M, low $675.08M), average EBITDA is $-151M (high $-150M, low $-153M), average net income is $-61.697M (high $-53.987M, low $-69.548M), average SG&A $544.82M (high $551.02M, low $539.9M), and average EPS is $-1.974 (high $-1.727, low $-2.225). IRTC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $799.63M (high $809.78M, low $791.65M), average EBITDA is $-177M (high $-175M, low $-179M), average net income is $-26.199M (high $-25.859M, low $-26.631M), average SG&A $639.5M (high $647.62M, low $633.12M), and average EPS is $-0.838 (high $-0.827, low $-0.852).
Did the IRTC's actual financial results beat the analysts' financial forecasts?
Based on iRhythm's last annual report (Dec 2022), the company's revenue was $410.92M, beating the average analysts forecast of $403.23M by 1.91%. Apple's EBITDA was $-85.14M, missing the average prediction of $-134M by -36.65%. The company's net income was $-116M, missing the average estimation of $-155M by -25.30%. Apple's SG&A was $322.2M, beating the average forecast of $317.79M by 1.39%. Lastly, the company's EPS was $-3.88, beating the average prediction of $-3.453 by 12.35%. In terms of the last quarterly report (Sep 2023), iRhythm's revenue was $124.6M, beating the average analysts' forecast of $122.61M by 1.63%. The company's EBITDA was $-27.603M, beating the average prediction of $-27.172M by 1.59%. iRhythm's net income was $-27.116M, beating the average estimation of $-19.897M by 36.28%. The company's SG&A was $93.77M, missing the average forecast of $98.05M by -4.37%. Lastly, the company's EPS was $-0.89, beating the average prediction of $-0.636 by 39.84%